Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 4
1980 2
1981 3
1982 2
1983 1
1985 1
1986 1
1990 2
1996 1
1998 1
2000 1
2001 3
2002 9
2003 1
2004 2
2005 6
2006 8
2007 6
2008 2
2009 2
2010 4
2011 1
2012 2
2013 5
2014 6
2015 6
2016 6
2017 5
2018 2
2019 6
2020 5
2021 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence for natural product drug discovery.
Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, Meijer D, Terlouw BR, Biermann F, Blin K, Durairaj J, Gorostiola González M, Helfrich EJN, Huber F, Leopold-Messer S, Rajan K, de Rond T, van Santen JA, Sorokina M, Balunas MJ, Beniddir MA, van Bergeijk DA, Carroll LM, Clark CM, Clevert DA, Dejong CA, Du C, Ferrinho S, Grisoni F, Hofstetter A, Jespers W, Kalinina OV, Kautsar SA, Kim H, Leao TF, Masschelein J, Rees ER, Reher R, Reker D, Schwaller P, Segler M, Skinnider MA, Walker AS, Willighagen EL, Zdrazil B, Ziemert N, Goss RJM, Guyomard P, Volkamer A, Gerwick WH, Kim HU, Müller R, van Wezel GP, van Westen GJP, Hirsch AKH, Linington RG, Robinson SL, Medema MH. Mullowney MW, et al. Among authors: reker d. Nat Rev Drug Discov. 2023 Nov;22(11):895-916. doi: 10.1038/s41573-023-00774-7. Epub 2023 Sep 11. Nat Rev Drug Discov. 2023. PMID: 37697042 Review.
"Inactive" ingredients in oral medications.
Reker D, Blum SM, Steiger C, Anger KE, Sommer JM, Fanikos J, Traverso G. Reker D, et al. Sci Transl Med. 2019 Mar 13;11(483):eaau6753. doi: 10.1126/scitranslmed.aau6753. Sci Transl Med. 2019. PMID: 30867323 Free PMC article. Review.
Artificial intelligence in chemistry and drug design.
Brown N, Ertl P, Lewis R, Luksch T, Reker D, Schneider N. Brown N, et al. Among authors: reker d. J Comput Aided Mol Des. 2020 Jul;34(7):709-715. doi: 10.1007/s10822-020-00317-x. J Comput Aided Mol Des. 2020. PMID: 32468207 Review. No abstract available.
Counting on natural products for drug design.
Rodrigues T, Reker D, Schneider P, Schneider G. Rodrigues T, et al. Among authors: reker d. Nat Chem. 2016 Jun;8(6):531-41. doi: 10.1038/nchem.2479. Epub 2016 Apr 25. Nat Chem. 2016. PMID: 27219696 Review.
Drug-induced dysphoria.
Anderson BG, Reker D, Cooper T. Anderson BG, et al. Among authors: reker d. Br J Psychiatry. 1996 Apr;168(4):520. doi: 10.1192/bjp.168.4.520a. Br J Psychiatry. 1996. PMID: 8730954 No abstract available.
Common non-epigenetic drugs as epigenetic modulators.
Lötsch J, Schneider G, Reker D, Parnham MJ, Schneider P, Geisslinger G, Doehring A. Lötsch J, et al. Among authors: reker d. Trends Mol Med. 2013 Dec;19(12):742-53. doi: 10.1016/j.molmed.2013.08.006. Epub 2013 Sep 18. Trends Mol Med. 2013. PMID: 24054876 Review.
112 results